Cell and cell-MATRIX INTERACTIONS IN TUMORS: CURRENT STATE OF THE PROBLEM

I.P. Pavlov Russian Medical Biological Herald ›› 2013, Vol. 21 ›› Issue (3) : 161 -171.

PDF
I.P. Pavlov Russian Medical Biological Herald ›› 2013, Vol. 21 ›› Issue (3) :161 -171. DOI: 10.17816/PAVLOVJ20133161-171
Articles
review-article

Cell and cell-MATRIX INTERACTIONS IN TUMORS: CURRENT STATE OF THE PROBLEM

Author information +
History +
PDF

Abstract

In an article in the form of a literature review highlights current understanding of cell-cell and cell-matrix interactions in tumors.

Keywords

tumor / breast cancer / cell-cell interactions / invasion / metastasis / stroma / regulation

Cite this article

Download citation ▾
null. Cell and cell-MATRIX INTERACTIONS IN TUMORS: CURRENT STATE OF THE PROBLEM. I.P. Pavlov Russian Medical Biological Herald, 2013, 21(3): 161-171 DOI:10.17816/PAVLOVJ20133161-171

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Абелев Г.И. Механизмы дифференцировки и опухолевый рост / Г.И. Абелев // Биохимия. − 2000. − Т. 65. − С. 126-137.

[2]

Абелев Г.И. Дифференцировочные антигены в опухолях – зависимость от механизмов канцерогенеза и прогрессии (гипотеза) / Г.И. Абелев // Молекулярная биология. − 2003. − Т. 37. − С. 4-11.

[3]

Куликова К.В. Внутриядерная локализация β-катенина не может считаться достаточным условием для активности канонического сигнального пути Wnt вклеточных линиях меланомы человека / К.В. Куликова, А.В. Посвятенко, Н.В. Гнучев // Молекулярная биология. − 2011. − Т. 45, №5. − С. 884-891.

[4]

Фильченков А.А. Визуализация и оценка апоптоза, вызванного противоопухолевой терапией: клинические перспективы / А.А. Фильченков // Онкология. − 2011. − Т. 13, №4(50). − С. 266-277.

[5]

Plasma tumor necrosis factor-a soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant women / B. Alberts [et al.] // Molecular biology. − 2005. − Vol. 265, №14. − P. 1209-1215.

[6]

Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction / S. Baritaki [et al.] // Oncogene. − 2009. − Vol. 28. − P. 3573-3585.

[7]

Barrallo-Gimeno A. The Snail genes as in-ducers of cell movement and survival: implications in development and cancer / A. Barrallo-Gimeno, M.A. Nieto // Development. − 2005. − Vol. 132. − P. 3151-3161.

[8]

Carpenterand G. Epidermal growth factor / G. Carpenterand, S. Cohen // J Biol. Chem. − 2000. − Vol. 265, № 14. − P. 7709-7712.

[9]

Campbell L.L. Breast tumor heterogeneity / L.L. Campbell, K. Polyak // Cell Cycle. − 2007. − Vol. 6, № 19. − P. 2332-2338.

[10]

Allelic imbalance in the clonal evolution of prostate carcinoma / L. Cheng [et al.] // Cancer. − 1999. − Vol. 85, № 9. − P. 2017-2022.

[11]

Citri A. EGF-ERBB signalling: towards the systems level / A. Citri, Y. Yarden // Nature Rev Molecular Cell. Biol. − 2006. − Vol. 7, № 7. − P. 505-516.

[12]

Taking cell-matrix adhesions to the third dimension / E. Cukierman [et al.] // Science. − 2001. − Vol.294. − P. 1708-1712.

[13]

Molecular and pathological signatures of epithelial–mesenchymaltransitions at the cancer invasion front / O. De Wever [et al.] // Histochem Cell Biol. – 2008. – Vol. 130. – Р. 481-494.

[14]

Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone / B.E. Elliott [et al.] // Int J Cancer. − 2008. − Vol. 51. − Р. 416-424.

[15]

Co-operative effect of cSrc and ezrin in deregulation of cell-cell contacts and scattering of mammary carcinoma cells / B.E. Elliott [et al.] // J Cell Biochem. − 2004. − Vol. 92. − Р. 16-28.

[16]

Fried P. Tumour-cell invasion and migration: diversity and escape mechanisms / P. Fried, К. Wolf // Nat. Rev. Cancer. − 2003. − Vol. 3. − P. 362-374.

[17]

Metabolic genes in cancer: their roles in tumor progression and clinical implications / E. Furata [et al.]. Biochim. Biophys. Acta Rev. Cancer. − 2010. − Vol. 1805, № 2. − P. 141-152.

[18]

Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis / J. Gotzmann [et al.] // Mutat. Res. − 2004. − Vol. 566. − P. 9-20.

[19]

Gos M. Epithelial-mesenchymal transition in cancer progression / M. Gos, J. Mijoszewska, M. Przybyszewska // Postepy Biochem. − 2009. − Vol. 55. − Р. 121-128.

[20]

Regulation of membrane type-matrix metalloproteinases / S. Hernandez-Barrantes [et al.] // Ibid. − 2002. − Vol. 12. − P. 131-138.

[21]

Heldin C.H. Dimerization of cell surface receptors in signal transduction / C.H. Heldin // Cell. − 2005. − Vol. 80, №2. − P. 213-223.

[22]

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma / M. Inda [et al.] Genes and dev. − 2010. − Vol. 24, №16. − P. 1731-1740.

[23]

Epithelialmesenchymal transition in cancer development and its clinical significance / M. Iwatsuki [et al.] // Cancer Sci. − 2010. − Vol. 101, № 2. − P. 293-299.

[24]

Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition / S. Julien [et al.] // Оncogene. − 2007. − Vol. 26. − P. 7445-7456.

[25]

Kenny P.A. Tumor reversion: Correction of malignant behavior by microenvi-ronmental cues / P.A. Kenny, M.J. Bissel // Int. J. Cancer. − 2003. − Vol. 107. − P. 688-695.

[26]

Krieg J. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin / J. Krieg, T. Hunter // J Biol Chem. − 1992. − Vol. 267. − P. 19258-19265.

[27]

The cytoskeleton of digestive epithelia in health and disease / N.O. Ku [et al.] // Am. J. Physiol. − 1999. − Vol. 277. − P. Gl 108-1137.

[28]

The membranecytoskeleton linker ezrin is necessary for osteosarcoma metastasis / C. Khanna [et al.] // Nat Med. − 2004. − Vol. 10. − P. 182-186.

[29]

The epithelial-mesenchymal transition: new insights in signaling, development, and disease / J.M. Lee [et al.] // J Cell Biol. − 2006. − Vol. 172. − P. 973-981.

[30]

Lord R.S. Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites / R.S. Lord, B. Bongiovanni, J.A. Bralley // Altern Med Rev. − 2002. − Vol. 7. − P. 12-29.

[31]

Supression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes / Q. Meng [et al.] // J. Mol. Med. − 2000. − Vol. 78, №3. − P. 155-165.

[32]

Micalizzi D.S. Epithelial-mesenchymal transition in development and cancer / D.S. Micalizzi, H.L. Ford // Future Oncol. − 2009. − Vol. 5, № 8. − P. 1129-1143.

[33]

Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment / N. Normanno [et al.] // Endocr Rel Cancer. − 2003. − Vol. 10, №1. − P. 1-21.

[34]

Nieto M.A. The snail superfamily of zinc-finger transcription factors / M.A. Nieto // Nat Rev Mol Cell Biol. − 2002. − Vol. 3. − P. 155-166.

[35]

Pantel K. Dissecting the metastatic cascade / K. Pantel, R.H. Brakenhoff // Nat Rev Cancer. − 2004. − Vol. 4. − P. 448-456.

[36]

Pietras A. Cancer stem cells in tumor heterogeneity / A. Pietras // Adv. Cancer Res. − 2011. − Vol. 112. − P. 255-281.

[37]

Polyak K. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits / K. Polyak, R.A. Weinberg // Nature Rev. Cancer. − 2009. − Vol. 9, № 4. − P. 265-273.

[38]

Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity / H. Qiao [et al.] // Cell Growth Differ. − 2000. − Vol. 11. − P. 123-133.

[39]

Cell migration: integrating signals from front to back / A.J. Ridley [et al.] // Science. − 2003. − Vol. 302. − P.1704-1709.

[40]

Stetler-Stevenson W. Proteases in invasion: matrix metalloproteinases / W. Stetler-Stevenson, A.E. Yu // Ibid. − 2001. − Vol. 11. − P. 143-152.

[41]

Function of the integrin α6β1 in metastatic breast carcinoma cells assessed by expression of a dominant negative receptor / L.M. Shaw [et al.] // Cancer Res. − 2006. − Vol. 56. − P. 959-963.

[42]

Snijder B. Origins of regulated cell-to-cell variability / B. Snijder, L. Pelkmans // Nature Rev. Mol. Cell Biol. − 2011. − Vol. 12, №2. − P. 119-125.

[43]

Molecular definition of breast tumor heterogeneity / M. Shipitsin [et al.] // Cancer Cell. − 2007. − Vol. 11, №3. − P. 259-273.

[44]

Tisty T.D. Tumor stroma and regulation of cancer development / T.D. Tisty, L.M. Coussens // Annu. Rev. Pathol. − 2006. − №1. − P. 119-150.

[45]

Thiery J.P. Epithelial-mesenchymal transitions in tumour progression / J.P. Thiery // Nat. Rev. Cancer. − 2002. − Vol. 2. − P. 442-154.

[46]

Tsuji T. Epithelial-mesenchymal transition and cell cooperativity in metastasis / T. Tsuji, S. Ibaragi, G.F. Hu // Cancer Res. − 2009. − Vol. 69. − P. 7135-7139.

[47]

Voulgari A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic / A. Voulgari, A. Pintzas // Biochim. Biophys. Acta Rev. Cancer. − 2009. − Vol. 1796, № 2. − P. 75-90.

[48]

Reciprocal interactions between (31-integrin and epidermal growth factoi receptor in three-dimensional basement membrane breas cultures: A different perspective in epithelial biology / F. Wang [et al.] // Proc Natl. Acad. Sci. USA. − 1998. − Vol. 95. − P. 14821-14826.

[49]

Gene expression profiles of primary breast tumors maintained in distant metastases / B. Weigelt [et al.]. Proc. Natl. Acad. Sci. USA. − 2003. − Vol. 100, №26. − P. 15901-15905.

RIGHTS & PERMISSIONS

Mnikhovich M.V.

PDF

132

Accesses

0

Citation

Detail

Sections
Recommended

/